and anti-leukemic drugs. The development of promising hDHODH inhibitors is in high demand. Based on the unique binding mode of our previous reported 4-thiazolidinone derivatives, via molecular docking method, three new series 4-thiazolidinone derivatives were designed and synthesized as hDHODH inhibitors. The preliminary structure–activity relationship was investigated. Compound 9 of biphenyl series
人类二氢
乳清酸脱氢酶(hDHODH)是开发
免疫抑制药物的有吸引力的靶标之一,也是抗癌药物和抗白血病药物的潜在靶标。开发有前景的 hDHODH
抑制剂的需求量很大。基于我们之前报道的4-
噻唑烷酮衍
生物的独特结合模式,通过分子对接方法,设计并合成了三个新系列的4-
噻唑烷酮衍
生物作为hDHODH
抑制剂。研究了初步的构效关系。
联苯系列化合物9和酰胺系列化合物37的IC50值分别为1.32 μM和1.45 μM。该研究将为hDHODH
抑制剂新结构的研究提供有价值的参考。